Gut-microbiota in the regulatory axes of metabolism
HTML (Spanish)
PDF (Spanish)

Keywords

gut-microbiota
microbiota and autoimmune diseases
microbiota-gut-brain axis

How to Cite

Serrano-Miranda, E. G. (2022). Gut-microbiota in the regulatory axes of metabolism. Pinelatinoamericana, 2(3), 225-239. https://revistas.psi.unc.edu.ar/index.php/pinelatam/article/view/38949

Abstract

The intercommunication in living organisms, among their cells, organs and systems is increasingly evident. An example of this are the results obtained by different groups of researchers, which demonstrate the function of bidirectional axes, in which the intestine and its microbiota participate as a common denominator.

Studies carried out mainly with bacteria demonstrated altered microbiota in patients with various pathologies, compared to their healthy controls. When reviewing the molecular elements that participate in it, inflammatory processes as important initiators in the alteration of the dynamic balance between the intestine and the microbiota attract attention as a common finding. The establishment of the chronic stage of inflammation allows and perpetuates the alteration of these axes that are involved in various autoimmune diseases with commitment and progressive deterioration of the Central Nervous System and neurodegeneration.

Conclusions. In this multifactorial process, the balance in the relationship of the immune system, with the intestine and its microbiota, participate in a suppression linked to tolerance carried out by all these systems. In turns, the generation of an inflammatory response favors an increase in the permeability of the barriers of the intestine, brain and certain organs, initiating an abnormal communication between nearby and/or distant cellular and tissue systems, generating a state of permanent inflammation that can reach to be chronic or "low grade", being the onset and persistence of various diseases with autoimmune components.

The results of various studies that will be reviewed and discussed highlight the importance of the metabolic axes between the gut-microbiota and their impact on the other organs of the body.

HTML (Spanish)
PDF (Spanish)

References

Abbott, N. J., Rönnbäck, L., y Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature reviews. Neuroscience, 7(1), 41–53. https://doi.org/10.1038/nrn1824.

Barnig, C., Bezema, T., Calder, P. C., Charloux, A., Frossard, N., Garssen, J., Haworth, O., Dilevskaya, K., Levi-Schaffer, F., Lonsdorfer, E., Wauben, M., Kraneveld, A. D., y Te Velde, A. A. (2019). Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Frontiers in immunology, 10, 1699. https://doi.org/10.3389/fimmu.2019.01699.

Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., Kümpfel, T., Hohlfeld, R., Krishnamoorthy, G., y Wekerle, H. (2017). Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proceedings of the National Academy of Sciences of the United States of America, 114(40), 10719–10724. https://doi.org/10.1073/pnas.1711233114

Bottasso, O. (2022). La inflamación en el siglo XXI, desde los conceptos clásicos a una visión más extendida. Pinelatinoamericana, 2(2), 116-124 https://revistas.unc.edu.ar/index.php/pinelatam/article/view/38192.

Butler, T. D., y Gibbs, J. E. (2020). Circadian Host-Microbiome Interactions in Immunity. Frontiers in immunology, 11, 1783. https://doi.org/10.3389/fimmu.2020.01783.

Castés, M. (2022). Programa de inmunoalfabetización basado en la psiconeuroinmunología, durante la pandemia del SARS-CoV-2. Pinelatinoamericana, 2(1), 17-26. https://revistas.unc.edu.ar/index.php/pinelatam/article/view/37220.

Cayres, L., de Salis, L., Rodrigues, G., Lengert, A., Biondi, A., Sargentini, L., Brisotti, J. L., Gomes, E., y de Oliveira, G. (2021). Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis. Frontiers in immunology, 12, 579140. https://doi.org/10.3389/fimmu.2021.579140.

Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., y Francavilla, R. (2021). Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Frontiers in immunology, 12, 578386. https://doi.org/10.3389/fimmu.2021.578386.

Coquant, G., Grill, J. P., y Seksik, P. (2020). Impact of N-Acyl-Homoserine Lactones, Quorum Sensing Molecules, on Gut Immunity. Frontiers in immunology, 11, 1827. https://doi.org/10.3389/fimmu.2020.01827.

Cox, L. M., Maghzi, A. H., Liu, S., Tankou, S. K., Dhang, F. H., Willocq, V., Song, A., Wasén, C., Tauhid, S., Chu, R., Anderson, M. C., De Jager, P. L., Polgar-Turcsanyi, M., Healy, B. C., Glanz, B. I., Bakshi, R., Chitnis, T., y Weiner, H. L. (2021). Gut Microbiome in Progressive Multiple Sclerosis. Annals of neurology, 89(6), 1195–1211. https://doi.org/10.1002/ana.26084.

Cussotto, S., Delgado, I., Anesi, A., Dexpert, S., Aubert, A., Beau, C., Forestier, D., Ledaguenel, P., Magne, E., Mattivi, F., y Capuron, L. (2020). Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation. Frontiers in immunology, 11, 557. https://doi.org/10.3389/fimmu.2020.00557.

De Luca, F., y Shoenfeld, Y. (2019). The microbiome in autoimmune diseases. Clinical and experimental immunology, 195(1), 74–85. https://doi.org/10.1111/cei.13158.

de Oliveira, G. L. V., Cardoso, C. R. V., Taneja, V. y Fasano, A. (2021) Editorial: Intestinal dysbiosis in inflammatories diseases. Front. Immunol. 12:727485. https://doi:10:3389/fimmu.2021.727485

Dempsey, E., y Corr, S. C. (2022). Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives. Frontiers in immunology, 13, 840245. https://doi.org/10.3389/fimmu.2022.840245.

Di Giovangiulio, M., Verheijden, S., Bosmans, G., Stakenborg, N., Boeckxstaens, G. E., y Matteoli, G. (2015). The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease. Frontiers in immunology, 6, 590. https://doi.org/10.3389/fimmu.2015.00590.

Eynard, A. R., (2021). Inflamación de “bajo grado” en el Sistema Nervioso y estrés crónico: aspectos celulares y moleculares básicos en su fisiopatología. Pinelatinoamericana 1(1), 3-11. https://revistas.unc.edu.ar/index.php/pinelatam/article/view/35444.

Henao-Pérez, J., López-Medina, D. C., Henao-Pérez, M., Castro-Rodríguez, V. C. y Castrillon-Aristizábal, M. (2021). Psiconeuroinmunoendocrinología de la respuesta al estrés, el ciclo circadiano y la microbiota en la artritis reumatoide. Rev. Colomb. Psiquiat. https://doi.org/10.1016/j.rep.2021. 10.003.

Horng, S., Therattil, A., Moyon, S., Gordon, A., Kim, K., Argaw, A. T., Hara, Y., Mariani, J. N., Sawai, S., Flodby, P., Crandall, E. D., Borok, Z., Sofroniew, M. V., Chapouly, C., y John, G. R. (2017). Astrocytic tight junctions control inflammatory CNS lesion pathogenesis. The Journal of clinical investigation, 127(8), 3136–3151. https://doi.org/10.1172/JCI91301.

Janakiraman, M., y Krishnamoorthy, G. (2018). Emerging Role of Diet and Microbiota Interactions in Neuroinflammation. Frontiers in immunology, 9, 2067. https://doi.org/10.3389/fimmu.2018.02067.

Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Schumm, L. P., Sharma, Y., Anderson, C. A., Essers, J., Mitrovic, M., Ning, K., Cleynen, I., Theatre, E., Spain, S. L., Raychaudhuri, S., Goyette, P., Wei, Z., Abraham, C., … Cho, J. H. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491(7422), 119–124. https://doi.org/10.1038/nature11582.

Leocádio, P., Oriá, R. B., Crespo-Lopez, M. E., y Alvarez-Leite, J. I. (2020). Obesity: More Than an Inflammatory, an Infectious Disease?. Frontiers in immunology, 10, 3092. https://doi.org/10.3389/fimmu.2019.03092.

Magistrelli, L., Amoruso, A., Mogna, L., Graziano, T., Cantello, R., Pane, M., y Comi, C. (2019). Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Frontiers in immunology, 10, 969. https://doi.org/10.3389/fimmu.2019.00969

Marietta, E., Mangalam, A. K., Taneja, V., y Murray, J. A. (2020). Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases. Frontiers in immunology, 11, 573079. https://doi.org/10.3389/fimmu.2020.573079.

Montiel-Castro, A. J., González-Cervantes, R. M., Bravo-Ruiseco, G., y Pacheco-López, G. (2013). The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Frontiers in integrative neuroscience, 7, 70. https://doi.org/10.3389/fnint.2013.00070.

Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., y Dong, B. (2022). Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging. Frontiers in immunology, 13, 796288. https://doi.org/10.3389/fimmu.2022.796288.

Pérez Torres, A. (2016). Arquitectura del sistema inmunológico en L. Pavón Romero, M. C. Jiménez Martínez y M. E. Garcés Alvarez (Ed). Inmunología molecular, celular y traslacional. (1ª ed., pp. 61-65) Wolters Kluwer.

Que, Y., Cao, M., He, J., Zhang, Q., Chen, Q., Yan, C., Lin, A., Yang, L., Wu, Z., Zhu, D., Chen, F., Chen, Z., Xiao, C., Hou, K., y Zhang, B. (2021). Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential. Frontiers in immunology, 12, 722206. https://doi.org/10.3389/fimmu.2021.722206.

Roden, M., y Shulman, G. I. (2019). The integrative biology of type 2 diabetes. Nature, 576(7785), 51–60. https://doi.org/10.1038/s41586-019-1797-8

Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., y Guggino, G. (2021). Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview. Frontiers in immunology, 12, 637829. https://doi.org/10.3389/fimmu.2021.637829

Sweeney, M. D., Sagare, A. P., y Zlokovic, B. V. (2018). Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nature reviews. Neurology, 14(3), 133–150. https://doi.org/10.1038/nrneurol.2017.188

Takewaki, D., Suda, W., Sato, W., Takayasu, L., Kumar, N., Kimura, K., Kaga, N., Mizuno, T., Miyake, S., Hattori, M., y Yamamura, T. (2020). Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 117(36), 22402–22412. https://doi.org/10.1073/pnas.2011703117.

Taleb S. (2019). Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases. Frontiers in immunology, 10, 2113. https://doi.org/10.3389/fimmu.2019.02113.

Vaahtovuo, J., Munukka, E., Korkeamäki, M., Luukkainen, R., y Toivanen, P. (2008). Fecal microbiota in early rheumatoid arthritis. The Journal of rheumatology, 35(8), 1500–1505.

Valle-Noguera, A., Ochoa-Ramos, A., Gomez-Sánchez, M. J., y Cruz-Adalia, A. (2021). Type 3 Innate Lymphoid Cells as Regulators of the Host-Pathogen Interaction. Frontiers in immunology, 12, 748851. https://doi.org/10.3389/fimmu.2021.748851

Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., y Dosch, H. M. (2009). Obesity predisposes to Th17 bias. European journal of immunology, 39(9), 2629–2635. https://doi.org/10.1002/eji.200838893.

Xu, Q., Ni, J. J., Han, B. X., Yan, S. S., Wei, X. T., Feng, G. J., Zhang, H., Zhang, L., Li, B., y Pei, Y. F. (2022). Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study. Frontiers in immunology, 12, 746998. https://doi.org/10.3389/fimmu.2021.746998

Zhang, L., y Chu, C. Q. (2021). Gut Microbiota-Medication Interaction in Rheumatic Diseases. Frontiers in immunology, 12, 796865. https://doi.org/10.3389/fimmu.2021.796865

Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., y Cheng, P. (2022). Inplications of gut microbiota in neurodegenerative diseases. Front. Immunol. 13:785644 https://doi:103389/fimmu.2022.785644.

Zhou, H., Wang, L., y Liu, F. (2021). Immunological Impact of Intestinal T Cells on Metabolic Diseases. Frontiers in immunology, 12, 639902. https://doi.org/10.3389/fimmu.2021.639902.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2022 Pinelatinoamericana

Downloads

Download data is not yet available.